Provide feedbackProvide feedback
Home :: Internal Medicine

Multifaceted quality improvement intervention in primary care practices benefits diabetes outcomes, findings show

Wednesday, December 17 2008 | Comments
Evidence Grade 2 What's This?

A multicomponent organizational intervention in the primary care setting has the potential to significantly increase the percentage of patients with type 2 diabetes who achieve recommended clinical goals, a new study concludes. To determine whether such an intervention could produce significant change in diabetes care and outcomes in community primary care practices, researchers randomized 24 community primary care practices to receive either the intervention or a control condition (a...

A multicomponent organizational intervention in the primary care setting has the potential to significantly increase the percentage of patients with type 2 diabetes who achieve recommended clinical goals, a new study concludes.

To determine whether such an intervention could produce significant change in diabetes care and outcomes in community primary care practices, researchers randomized 24 community primary care practices to receive either the intervention or a control condition (a report of process and outcome measures at baseline and encouragement to continue usual quality improvements).

The intervention included implementation of an electronic diabetes registry, visit reminders, and patient-specific physician alerts. In addition, a site coordinator facilitated both previsit planning and a monthly review of performance with a local physician assigned to act as program advocate (ie, a "local physician champion"). Work flow changes in the intervention group included identification and case management of patients not achieving goals, provider alerts with integrated decision support during visits, and monthly reviews by the local physician champion with feedback to individual providers, the researchers noted.

The researchers evaluated the percentages of patients achieving target values for systolic blood pressure (SBP <130 mmHg), low-density lipoprotein (LDL) cholesterol (LDL cholesterol <100 mg/dL), and hemoglobin A1C (A1C <7%). They also evaluated improvements in rates of 6 process measures: blood pressure monitoring, renal testing, annual eye examinations, foot examinations, A1C testing, and LDL cholesterol testing.

Twelve months after the researchers introduced the multicomponent intervention program, primary care practices in the intervention group improved significantly more than control practices in their ability to help patients with diabetes achieve recommended clinical targets.

Both groups achieved significant declines in mean SBP and LDL cholesterol levels, but only the intervention group achieved significant declines in A1C (P<.02) in analyses adjusted for age, sex, and comorbidity. Intervention practices also had significantly higher proportions of patients who achieved target levels for SBP (45.0% vs 40.6%; P<.001), LDL cholesterol (43.0% vs 35.5%; P<.001), and A1C (49.0% vs 43.8%; P<.001).

At 12 months, the net improvement in the average number of recommended clinical targets (SBP, LDL cholesterol, and A1C) achieved from baseline to 12 months among all patients was significantly greater among the intervention practices than among the control practices (P=.002).

In addition, from the 12-month period before the intervention to the 12-month period following its implementation, intervention practices showed significantly greater improvement in rates of all 6 process measures as compared with control practices.

"This combination of components provides a proven strategy for initiating improvement in clinical diabetes care for many primary care practices," concluded the authors. (Peterson KA, et al. Diabetes Care 2008;31:2238–2243.)

Latest News

Prophylactic cephalosporin for urinary reflux increases risk of extended-spectrum beta-lactamase-producing bacteria for breakthrough UTIs Verusmed

Tuesday, December 16 2008 | Comments
Evidence Grade 3 What's This?
Children with vesicoureteral reflux (VUR) receiving cephalosporin prophylaxis are at an increased risk of having extended-spectrum beta-lactamase (ESBL)-producing bacteria or multidrug-resistant uropathogens for breakthrough urinary tract infections (UTIs), a new retrospective study concludes.

Researchers in Taiwan sought to examine bacterial antimicrobial resistance of recurrent UTIs in children receiving antibiotic prophylaxis because of primary VUR. To do so, they analyzed...

Two studies fail to show benefit of aspirin for primary prevention of cardiovascular events in patients with diabetes Verusmed

Wednesday, November 12 2008 | Comments
Evidence Grade 2 What's This?
Results from 2 new studies do not support the use of aspirin for the primary prevention of cardiovascular events in people with diabetes.

In the first trial, which was conducted in Japan, low-dose aspirin did not seem to prevent cardiovascular events in people with type 2 diabetes, although researchers noted a possible benefit in the older participants.

The prospective, randomized, open-label study enrolled 2,539 individuals aged 30 to 85 years who had type 2...


Dizziness, vertigo common, warrant attention in primary care, research suggests Verusmed

Wednesday, November 05 2008 | Comments
Evidence Grade 11 What's This?
Dizziness and vertigo are frequent symptoms that warrant increased attention from primary care providers, cross-sectional study data suggest.

The study investigators noted that previous research suggests dizziness and vertigo are among the most frequent complaints in primary care, but the cause remains unexplained in 40% to 80% of cases. To evaluate the contribution of vestibular vertigo to the burden of dizziness and to assess the overall burden of dizziness in the community,...

Aspirin, antioxidants not effective in primary prevention of cardiovascular events in patients with diabetes, study shows Verusmed

Wednesday, November 05 2008 | Comments
Evidence Grade 2 What's This?
Aspirin and antioxidants do not appear to be effective in the primary prevention of cardiovascular events in patients with diabetes and asymptomatic peripheral arterial disease, concludes a randomized, controlled trial.

Clinical guidelines including those from the American Heart Association and the American Diabetes Association suggest that antiplatelet therapy is appropriate for the primary...